Shenzhen Salubris Pharmaceuticals Co.Ltd(002294)
Report on the work of independent directors in 2021
Shareholders and shareholder representatives:
I was elected as an independent director of the company at the general meeting of shareholders on December 17, 2021. Since taking office,
In strict accordance with relevant regulations and requirements, I scrupulously perform my duties, perform my duties diligently, and perform the duties of independent director independently and impartially
Business. I hereby report my performance of duties as an independent director during my term of office as follows:
1、 Attendance at the board of directors and shareholders’ meeting
(I) during my term of office in 2021, the company held a total of one board meeting. See for the specific attendance
The following table:
The independent director shall attend the on-site meeting by means of communication, whether the name is continuous, the number of times of attendance, the number of times of attendance, the number of times of absence, and the number of times of not attending the meeting in person
Wang Xuegong 1 0 1 0 0 0 no
(II) during my tenure in 2021, the company did not hold a general meeting of shareholders; As the fifth director
Candidates for independent directors of the board of directors attended the third extraordinary general meeting of shareholders in 2021.
2、 Independent opinions
In 2021, I actively attended relevant meetings, carefully considered various proposals and adopted a reasonable and cautious attitude,
Make an independent and impartial judgment. The independent opinions jointly expressed with other independent directors on relevant matters are as follows:
No. event time opinion type
1. On the appointment of financial director, it was agreed on December 30, 2021
2. The provision for asset impairment was agreed on December 30, 2021
3、 Work of the special committee of the board of directors
As the nomination convener of the board of directors, in 2021, I organized and held a nomination committee meeting to review the candidates for senior management of the company and put forward reasonable opinions.
4、 On site inspection of the company
My term of office in 2021 is short. During my term of office, I used my time to attend the general meeting of shareholders to understand the continuous improvement and implementation of the company’s production and operation, management and internal control system, and the implementation of the resolutions of the board of directors. The cumulative number of on-site inspection days was 1.5 days. I keep in touch with other directors, supervisors, management and relevant personnel of the company, listen to the relevant reports of the company’s management on the operation status and standardized operation, timely learn the progress of major matters of the company, master the operation and management dynamics of the company, and ensure that the supervision and guidance functions of independent directors are brought into play.
5、 Other work done in protecting the rights and interests of investors
1. Pay attention to the company’s internal control and corporate governance structure
As an independent director, I actively communicated with relevant personnel of the company by consulting relevant materials and asking relevant personnel, so as to deeply understand the operation and financial status of the company and the progress of various major matters; Supervise and inspect the performance of senior executives; For major matters that need to be considered and decided by the board of directors, carefully review the materials provided by the company. If in doubt, take the initiative to ask relevant personnel to understand the specific situation. On this basis, use professional knowledge, make independent and objective judgment, exercise voting rights prudently, and earnestly perform the due duties of independent directors.
2. Supervise and inspect the information disclosure of the company
I continue to pay attention to the company’s information disclosure, urge the company to perform its information disclosure obligations in strict accordance with the requirements of laws and regulations such as the securities law and the Listing Rules of Shenzhen Stock Exchange, supervise and inspect the authenticity, accuracy and integrity of the company’s information disclosure, and protect the majority of investors’ right to know.
3. Work during 2021 Annual Report
During the preparation and disclosure of the 2021 annual report, I listened carefully to the company’s management’s report on the development trend, operation and financial status of the industry, fully and effectively communicated with the financial director and annual audit accountant through the audit committee, paid attention to the overall arrangement and progress of the annual report audit, and urged the external audit institutions to complete the audit work on time.
6、 And training
Since taking office, I have always paid attention to the study of laws, regulations and relevant rules and regulations, constantly strengthened my understanding of relevant regulations and laws and regulations related to regulating corporate governance and protecting the interests of social public shareholders, actively participated in various training and learning activities organized by regulatory authorities, continuously improved my ability to perform my duties, and provided better and more professional opinions and suggestions for the company’s scientific decision-making and risk prevention, Promote the company’s further standardized operation. 7、 Other working conditions
During my tenure in 2021, I did not propose to convene the board of directors or extraordinary general meeting of shareholders; There is no independent external audit institution and consulting company to audit and consult the specific matters of the company; Through the proposal of the audit committee, Daxin Certified Public Accountants (special general partnership) is proposed to be reappointed as the audit institution of the company in 2022.
8、 Problems and suggestions of the company
The company operates steadily and operates in a standardized manner. It is suggested that the company continuously improve the corporate governance structure and internal control system, continue to standardize the operation, and lay a solid foundation for the sustainable and healthy development of the company.
9、 Contact information
Name: Wang Xuegong
mail box: [email protected].
In 2022, I will continue to perform the duties of independent directors independently, objectively and impartially in the spirit of diligence, give full play to the role of independent directors, improve the scientific decision-making of the board of directors, and safeguard the legitimate rights and interests of the company and shareholders, especially minority shareholders.
It is hereby reported
Signature of independent director:
Wang Xuegong
March 25, 2002
